Application Nr Approved Date Route Status External Links
ANDA077673 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Efavirenz Tablets In Combination With Other Antiretroviral Agents Are Indicated For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adults And In Pediatric Patients At Least 3 Months Old And Weighing At Least 3.5 Kg. Efavirenz Tablets Are A Non-Nucleoside Reverse Transcriptase Inhibitor Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 Infection In Adults And In Pediatric Patients At Least 3 Months Old And Weighing At Least 3.5 Kg. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Efavirenz EFAVIRENZ ZINC2020233

Comments